Literature DB >> 2964458

Role of anxiety and anger in acne patients: a relationship with the severity of the disorder.

S F Wu1, B N Kinder, T N Trunnell, J E Fulton.   

Abstract

Studies investigating the possible role of personality and emotional factors in acne patients have yielded inconsistent and sometimes contradictory results. In the present study acne patients self-rated the severity of their conditions as mild, moderate, or severe and were compared to a control group on several personality variables. These self-ratings were compared to the objective ratings made by their dermatologists. Acne patients who self-rated their conditions as severe were found to experience significantly higher levels of trait anxiety than patients with mild and moderate conditions and control subjects; patients with severe and moderate conditions showed a higher state of anxiety than control subjects. Acne patients rated as severe by their dermatologists showed higher states of anxiety, "anger-in," and "anger-out" than the others. No other significant differences in terms of severity emerged, supporting the view that acne patients are not markedly neurotic. The results suggest that anxiety and anger are significant factors for severe acne patients and that future research should include severity ratings from both patients and physicians in the research design.

Entities:  

Mesh:

Year:  1988        PMID: 2964458     DOI: 10.1016/s0190-9622(88)70047-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

Review 1.  Isotretinoin, depression and suicide: a review of the evidence.

Authors:  Parker Magin; Dimity Pond; Wayne Smith
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

2.  Psychological sequelae of acne vulgaris: results of a qualitative study.

Authors:  Parker Magin; Jon Adams; Gaynor Heading; Dimity Pond; Wayne Smith
Journal:  Can Fam Physician       Date:  2006-08       Impact factor: 3.275

Review 3.  Quality-of-life outcomes and measurement in childhood atopic dermatitis.

Authors:  Sarah L Chamlin; Mary-Margaret Chren
Journal:  Immunol Allergy Clin North Am       Date:  2010-07-01       Impact factor: 3.479

4.  Effect of isotretinoin on the quality of life of patients with acne.

Authors:  N Simpson
Journal:  Pharmacoeconomics       Date:  1994-08       Impact factor: 4.981

5.  Responsiveness of the Dermatology-specific Quality of Life (DSQL) instrument to treatment for acne vulgaris in a placebo-controlled clinical trial.

Authors:  R Anderson; R Rajagopalan
Journal:  Qual Life Res       Date:  1998-12       Impact factor: 4.147

6.  Severe teenage acne and risk of endometriosis.

Authors:  Jing Xie; Marina Kvaskoff; Yunhui Li; Mingfeng Zhang; Abrar A Qureshi; Stacey A Missmer; Jiali Han
Journal:  Hum Reprod       Date:  2014-08-19       Impact factor: 6.918

Review 7.  Retinoic acid and affective disorders: the evidence for an association.

Authors:  J Douglas Bremner; Kirsty D Shearer; Peter J McCaffery
Journal:  J Clin Psychiatry       Date:  2011-08-23       Impact factor: 4.384

8.  Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials.

Authors:  C J Girman; S Hartmaier; D Thiboutot; J Johnson; B Barber; C DeMuro-Mercon; J Waldstreicher
Journal:  Qual Life Res       Date:  1996-10       Impact factor: 4.147

9.  Comparison of anxiety and depression in patients with acne vulgaris and healthy individuals.

Authors:  Javad Golchai; Soghra Hosain Khani; Abtin Heidarzadeh; Shahriar Sadre Eshkevari; Narges Alizade; Hojate Eftekhari
Journal:  Indian J Dermatol       Date:  2010-10       Impact factor: 1.494

10.  The impact of acne vulgaris on quality of life and psychic health in young adolescents in Greece. Results of a population survey.

Authors:  Eleni Tasoula; Stamatis Gregoriou; John Chalikias; Dimitris Lazarou; Ifigenia Danopoulou; Andreas Katsambas; Dimitris Rigopoulos
Journal:  An Bras Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.